These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 23110942)

  • 1. Impaired regulatory function in circulating CD4(+)CD25(high)CD127(low/-) T cells in patients with myasthenia gravis.
    Thiruppathi M; Rowin J; Ganesh B; Sheng JR; Prabhakar BS; Meriggioli MN
    Clin Immunol; 2012 Dec; 145(3):209-23. PubMed ID: 23110942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced frequency and functional defects of CD4
    Luo L; Zeng X; Huang Z; Luo S; Qin L; Li S
    Reprod Biol Endocrinol; 2020 Jun; 18(1):62. PubMed ID: 32522204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of interleukin (IL)-21 and CD4
    Alahgholi-Hajibehzad M; Durmuş H; Aysal F; Gülşen-Parman Y; Oflazer P; Deymeer F; Saruhan-Direskeneli G
    Clin Exp Immunol; 2017 Nov; 190(2):201-207. PubMed ID: 28671717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Requirement of cognate CD4+ T-cell recognition for the regulation of allospecific CTL by human CD4+ CD127- CD25+ FOXP3+ cells generated in MLR.
    Yu Y; Miller J; Leventhal JR; Tambur AR; Chandrasekaran D; Levitsky J; Luo X; Mathew JM
    PLoS One; 2011; 6(7):e22450. PubMed ID: 21799858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased frequency and suppressive activity of CD127(low/-) regulatory T cells in the peripheral circulation of patients with head and neck squamous cell carcinoma are associated with advanced stage and nodal involvement.
    Drennan S; Stafford ND; Greenman J; Green VL
    Immunology; 2013 Nov; 140(3):335-43. PubMed ID: 23826668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrease of CD4(+) CD25(+) CD127(low) FoxP3(+) regulatory T cells with impaired suppressive function in untreated ulcerative colitis patients.
    Mohammadnia-Afrouzi M; Zavaran Hosseini A; Khalili A; Abediankenari S; Hosseini V; Maleki I
    Autoimmunity; 2015; 48(8):556-61. PubMed ID: 26333292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of FoxP3+CD4+CD25hi Tregs in the pathogenesis of myasthenia gravis.
    Zhang Y; Wang HB; Chi LJ; Wang WZ
    Immunol Lett; 2009 Jan; 122(1):52-7. PubMed ID: 19111574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
    Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY
    Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of Treg-associated molecules on CD4+CD25 +Treg cells in myasthenia gravis and effects of immunosuppressants.
    Xu WH; Zhang AM; Ren MS; Zhang XD; Wang F; Xu XC; Li Q; Wang J; Din BS; Wu YB; Chen GH
    J Clin Immunol; 2012 Oct; 32(5):975-83. PubMed ID: 22467037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of up-regulating CD4(+)CD25(+) Tregs by IFN-γ in myasthenia gravis patients.
    Huang S; Wang W; Chi L
    BMC Neurol; 2015 Sep; 15():163. PubMed ID: 26347149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD2 costimulation reveals defective activity by human CD4+CD25(hi) regulatory cells in patients with multiple sclerosis.
    Baecher-Allan CM; Costantino CM; Cvetanovich GL; Ashley CW; Beriou G; Dominguez-Villar M; Hafler DA
    J Immunol; 2011 Mar; 186(6):3317-26. PubMed ID: 21300823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Adipose Tissue-Derived Mesenchymal Stromal Cells Inhibit CD4+ T Cell Proliferation and Induce Regulatory T Cells as Well as CD127 Expression on CD4+CD25+ T Cells.
    Fiori A; Uhlig S; Klüter H; Bieback K
    Cells; 2021 Jan; 10(1):. PubMed ID: 33401501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.
    Shen LS; Wang J; Shen DF; Yuan XL; Dong P; Li MX; Xue J; Zhang FM; Ge HL; Xu D
    Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased regulatory function of CD4
    Sheikh V; Zamani A; Mahabadi-Ashtiyani E; Tarokhian H; Borzouei S; Alahgholi-Hajibehzad M
    Scand J Immunol; 2018 Oct; 88(4):e12711. PubMed ID: 30270447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Providence of the CD25
    Chakraborty S; Bhattacharjee P; Panda AK; Kajal K; Bose S; Sa G
    Immunol Cell Biol; 2018 Nov; 96(10):1035-1048. PubMed ID: 29768737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of regulatory T cells in septic patients by real-time PCR-based methylation assay and flow cytometry.
    Tatura R; Zeschnigk M; Adamzik M; Probst-Kepper M; Buer J; Kehrmann J
    PLoS One; 2012; 7(11):e49962. PubMed ID: 23209626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both Treg cells and Tconv cells are defective in the Myasthenia gravis thymus: roles of IL-17 and TNF-α.
    Gradolatto A; Nazzal D; Truffault F; Bismuth J; Fadel E; Foti M; Berrih-Aknin S
    J Autoimmun; 2014 Aug; 52():53-63. PubMed ID: 24405842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction with activated monocytes enhances cytokine expression and suppressive activity of human CD4+CD45ro+CD25+CD127(low) regulatory T cells.
    Walter GJ; Evans HG; Menon B; Gullick NJ; Kirkham BW; Cope AP; Geissmann F; Taams LS
    Arthritis Rheum; 2013 Mar; 65(3):627-38. PubMed ID: 23280063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cord blood derived CD4+ CD25(high) T cells become functional regulatory T cells upon antigen encounter.
    Mayer E; Bannert C; Gruber S; Klunker S; Spittler A; Akdis CA; Szépfalusi Z; Eiwegger T
    PLoS One; 2012; 7(1):e29355. PubMed ID: 22272233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced CD4+,CD25- T cell sensitivity to the suppressive function of CD4+,CD25high,CD127 -/low regulatory T cells in patients with active systemic lupus erythematosus.
    Venigalla RK; Tretter T; Krienke S; Max R; Eckstein V; Blank N; Fiehn C; Ho AD; Lorenz HM
    Arthritis Rheum; 2008 Jul; 58(7):2120-30. PubMed ID: 18576316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.